Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Scolyer · SciRah

Researcher profile · Semantic Scholar

R. Scolyer

Share profile

R. Scolyer — researcher profile on SciRah

h-index: 108
Works: 969
Citations: 55K

Most-cited papers

Cutaneous melanoma.
Ge Long, S. Swetter, A. Menzies, J. Gershenwald +1 more
2023The Lancet362 citations Open access
Semantic Scholar
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
R. Simpson, E. Shanahan, R. Scolyer, Ge Long
2023Nature Reviews Clinical Oncology143 citations
Semantic Scholar
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su-Yin Lim, E. Shklovskaya, Jenny H. J. Lee, Bernadette Pedersen +10 more
2023Nature Communications137 citations Open access
Semantic Scholar
Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy.
Camelia Quek, A. Pratapa, Xin-Yu Bai, Ghamdan Al-Eryani +18 more
2024Cell Reports83 citations Open access
Semantic Scholar
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now.
G. Long, A. Menzies, R. Scolyer
2023Journal of Clinical Oncology83 citations
Semantic Scholar
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
I. Reijers, Disha Rao, J. Versluis, A. Menzies +22 more
2023Journal of Experimental Medicine78 citations Open access
Semantic Scholar
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Nicholas C. Allen, Andrew J. Martin, V. Snaidr, Renee Eggins +41 more
2023New England Journal of Medicine71 citations
Semantic Scholar
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions
R. Barnhill, D. Elder, M. Piepkorn, S. Knezevich +30 more
2023JAMA Network Open63 citations Open access
Semantic Scholar
CD4+ T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses
Emma Bawden, Teagan Wagner, Jan Schroeder, M. Effern +26 more
2024Science immunology62 citations
Semantic Scholar
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial.
S. Menzies, Christoph Sinz, Michelle Menzies, S. Lo +37 more
2023The Lancet Digital Health62 citations Open access
Semantic Scholar
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
A. V. van Akkooi, T. Hieken, E. Burton, C. Ariyan +37 more
2022Annals of Surgical Oncology42 citations Open access
Semantic Scholar
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
C. Garbe, R. Dummer, T. Amaral, R. Amaria +22 more
2023Nature Medicine39 citations Open access
Semantic Scholar
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
R. Bagge, R. Mikiver, Michael A. Marchetti, S. Lo +10 more
2024JAMA Surgery31 citations Open access
Semantic Scholar
Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?
C. Semsarian, T. Ma, Brooke Nickel, R. Scolyer +6 more
2022British Journal of Dermatology31 citations Open access
Semantic Scholar
Prognostic and predictive biomarkers in melanoma.
N. G. Maher, I. A. Vergara, Ge Long, R. Scolyer
2023Pathology (Sydney)30 citations
Semantic Scholar
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
R. C. Stassen, C. Maas, A. V. D. Van Der Veldt, S. Lo +11 more
2024The Lancet Oncology29 citations Open access
Semantic Scholar
Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies
N. Adegoke, T. Gide, Yi-Zhe Mao, Camelia Quek +9 more
2023Journal for ImmunoTherapy of Cancer28 citations Open access
Semantic Scholar
Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies
T. Gide, E. Paver, Zarwa Yaseen, N. Maher +6 more
2023Oncoimmunology28 citations Open access
Semantic Scholar
The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment.
A. McLean, S. Kao, D. J. Barnes, K. Wong +3 more
2022Lung Cancer28 citations
Semantic Scholar
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.
A. Menzies, S. Lo, R. Saw, Maria Gonzalez +14 more
2024Annals of Oncology18 citations
Semantic Scholar
Intratumoral CD16+ macrophages are associated with clinical outcomes of patients with metastatic melanoma treated with combination anti-PD-1 and anti-CTLA-4 therapy.
Hansol Lee, A. Ferguson, Camelia Quek, Ismael A. Vergara +17 more
2023Clinical Cancer Research18 citations Open access
Semantic Scholar
Abstract CT002: KEYMAKER-U02 substudy 02C: neoadjuvant pembrolizumab (pembro) + vibostolimab (vibo) or gebasaxturev (geba) or pembro alone followed by adjuvant pembro for stage IIIB-D melanoma
R. Dummer, C. Robert, R. Scolyer, J. Taube +15 more
2023Cancer Research17 citations
Semantic Scholar
Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
James R. Miller, S. Lo, M. Nosrati, J. Stretch +10 more
2023JAMA Network Open17 citations Open access
Semantic Scholar
Health Economic Consequences Associated With COVID-19–Related Delay in Melanoma Diagnosis in Europe
L. V. Maul, Dagmar Jamiolkowski, Rebecca Lapides, A. Mueller +22 more
2024JAMA Network Open15 citations Open access
Semantic Scholar
In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case–control study
B. Gouveia, G. Carlos, A. Wadell, Christoph Sinz +6 more
2023Journal of the European Academy of Dermatology and Venereology15 citations Open access
Semantic Scholar
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis
K. Nahar, Felix Marsh-Wakefield, R. Rawson, T. Gide +14 more
2022JCI Insight15 citations Open access
Semantic Scholar
Uncovering the complex relationship between balding, testosterone and skin cancers in men
Jue-Sheng Ong, M. Seviiri, J. Dusingize, Yeda Wu +18 more
2023Nature Communications14 citations Open access
Semantic Scholar
Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients
S. Lo, G. Williams, A. Cust, A. Varey +3 more
2024Journal of the National Cancer Institute13 citations Open access
Semantic Scholar
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
A. Varey, I. Li, M. El Sharouni, Julie M Simon +18 more
2024Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
C. Gjørup, Rachel Woodford, I. Li, M. Carlino +18 more
2023Annals of Surgical Oncology13 citations Open access
Semantic Scholar
Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy.
A. Rogiers, F. Dimitriou, Irene Lobon, Catriona Harvey +7 more
2023European Journal of Cancer12 citations
Semantic Scholar
Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.
E. Paver, T. Ahmed, H. Burke, R. Saw +8 more
2023JAMA dermatology12 citations
Semantic Scholar
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes.
M. El Sharouni, R. Rawson, A. Potter, E. Paver +8 more
2022Journal of American Academy of Dermatology11 citations
Semantic Scholar
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
Yi-Zhe Mao, T. Gide, N. Adegoke, Camelia Quek +14 more
2023Journal of Translational Medicine10 citations Open access
Semantic Scholar
Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine
Kevin Y. X. Wang, Gulietta M. Pupo, V. Tembe, Ellis Patrick +8 more
2022npj Digital Medicine10 citations Open access
Semantic Scholar
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
D. Schadendorf, J. Luke, P. Ascierto, Georgina V. Long +16 more
2024Journal for ImmunoTherapy of Cancer9 citations Open access
Semantic Scholar
Molecular and clinical correlates of HER3 expression highlights its potential role as a therapeutic target in melanoma.
Eva R. Shteinman, Ismael A. Vergara, R. Rawson, S. Lo +7 more
2023Pathology (Sydney)9 citations Open access
Semantic Scholar
KEYVIBE-010: Adjuvant coformulated vibostolimab with pembrolizumab versus adjuvant pembrolizumab in patients with high-risk stage II-IV melanoma.
G. Long, A. Eggermont, J. Gershenwald, D. Schadendorf +13 more
2023Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi
A. Colebatch, C. Adhikari, R. Diefenbach, R. Rawson +7 more
2022American Journal of Surgical Pathology9 citations
Semantic Scholar
The impact of response-directed surgery and adjuvant therapy on long-term survival after neoadjuvant ipilimumab plus nivolumab in stage III melanoma: Three-year data of PRADO and OpACIN-neo.
I. Reijers, A. Menzies, J. Versluis, R. Saw +16 more
2023Journal of Clinical Oncology8 citations
Semantic Scholar
VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis
J. Conway, Jorja Braden, S. Lo, R. Scolyer +4 more
2023Cancers8 citations Open access
Semantic Scholar
Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.
M. El Sharouni, R. Scolyer, C. V. van Gils, S. Ch'ng +11 more
2022European Journal of Cancer7 citations Open access
Semantic Scholar
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort
Lisanne P. Zijlker, Henry Chen, A. Spillane, Maria Gonzalez +15 more
2024Annals of Surgical Oncology6 citations Open access
Semantic Scholar
Interobserver agreement in the histopathological classification of desmoplastic melanomas
C. Lezcano, M. Berwick, Li Luo, R. Barnhill +9 more
2023Pathology (Sydney)6 citations Open access
Semantic Scholar
Junctional Nevus and Early Melanoma on Sun-Damaged Skin of the Head/Neck: a Clinico-Pathologic Challenge
E. Moscarella, P. Guitera, R. Scolyer, L. Rocha +5 more
2023Dermatology Practical & Conceptual6 citations Open access
Semantic Scholar
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases
A. Lawless, D. Coker, S. Lo, T. Ahmed +8 more
2022Annals of Surgical Oncology6 citations Open access
Semantic Scholar
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
A. Colebatch, E. Paver, Ismael A. Vergara, John F. Thompson +3 more
2022Pathology (Sydney)6 citations
Semantic Scholar
IFNγ signaling sensitizes melanoma cells to BH3 Mimetics.
Zizhen Ming, Su-Yin Lim, Ashleigh Stewart, Bernadette Pedersen +8 more
2023Journal of Investigative Dermatology5 citations
Semantic Scholar
Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerations.
Ruta Gupta, C. Selinger, B. Ashford, M. Chua +10 more
2023Pathology (Sydney)5 citations
Semantic Scholar
Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets.
Ismael A. Vergara, K. Aivazian, M. Carlino, A. Guminski +7 more
2023Modern Pathology5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Menzies×19
Invite
A. Menzies — researcher profile on SciRah
R. Saw×17
Invite
R. Saw — researcher profile on SciRah
S. Lo×13
Invite
S. Lo — researcher profile on SciRah
J. Wilmott×12
Invite
J. Wilmott — researcher profile on SciRah

×11

Invite

G. Long — researcher profile on SciRah

Invite

Ge Long — researcher profile on SciRah

Invite

M. Carlino — researcher profile on SciRah

Invite

A. Spillane — researcher profile on SciRah

Invite

R. Rawson — researcher profile on SciRah

Invite

K. Shannon — researcher profile on SciRah

Invite

S. Ch'ng — researcher profile on SciRah

Invite

S. Lo — researcher profile on SciRah